Changes in receptor levels for thyrotropin releasing hormone, serotonin, and substance P in cervical spinal cord of Wobbler mouse: A quantitative autoradiography study during early and late stages of the motoneuron disease

Brain Research

Volumn 725, Issue 1, 1996, Pages 49-60

  Deng, Y P ^a,b   Li, X S ^a   Zhang, S H ^a   Vacca Galloway, L L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Motoneuron disease; Quantitative autoradiography; Receptor; Serotonin; Spinal cord; Substance P; Thyrotropin releasing hormone; Wobbler mouse

Indexed keywords

PROTIRELIN; SEROTONIN; SUBSTANCE P;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEREDITARY SPINAL MUSCULAR ATROPHY; MOUSE; NERVE DEGENERATION; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SPINAL CORD VENTRAL HORN;

EID: 0030600010     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00244-2     Document Type: Article

References (113)

1. [1] Andrews, J.M. and Andrews, R.L., The comparative neuropathology of the motoneuron disease. In J.M. Andrews, M.T. Johnson and M.A.B. Brazier M.A.B. (Eds.), Amyotrophic Lateral Sclerosis: Recent Research Trends, Academic Press, New York, 1976, pp. 181-216.
2. [2] Barbeau, H. and Bedard, P., Similar motor effects of 5-HT and TRH in rats following chronical spinal transection and 5,7-dihydroxytryptamine injection, Neuropharmacology, 20 (1981) 477-481.
3. [3] Baulae, M., Rieger, F. and Meininger, V., The loss of motoneurons corresponding to specific muscles in the Wobbler mutant mouse, Neurosci. Lett., 37 (1983) 99-104.
4. [4] Bennett, G.W., Edwards. R.M., Ford, A.P.D.W., Pepper, J.M. and Marsden, C., Chronic immunological blockade of brain TRH or neurotensin alters both peptide-and amine-induced behaviours. In: Central Neuropeptides: From Gene to Behaviour, The European Neuroscience Assoc. and Rhone-Poulenc Santé, Paris, p. 53.
5. [5] Bird, M.T., Shuttleworth, E. Jr., Koestner, A. and Reinglass, J., The Wobbler mouse mutant: an animal model of hereditary motor system disease, Acta Neuropathol. (Berl.), 19 (1971) 39-50.
6. [6] Bowker, R.M., Westlund, K.N., Sullivan, M.C. and Coulter, J.D., Organization of descending serotonergic projections to the spinal cord, Prog. Brain Res., 57 (1982) 239-265.
7. [7] Bowker, R.M., Serotonergic and peptidergic inputs to the primate ventral spinal cord as visualized with multiple chromagens on the same tissue section, Brain Res., 375 (1986) 345-350.
8. [8] Burt, D.R., Max, S.R. and Hoffman, P.M., Decreases in spinal receptors for thyrotropin-releasing hormone precede symptom development in murine leukemia virus induced motor neuron disease, Soc. Neurosci. Abst., 10 (1984) 1093.
9. [9] Charlton, G., Brennan, M.J.W. and Ford, D.M., Alterations in neuro-transmitter receptor binding in the spinal cord after transection, Brain Res., 218 (1981) 372-375.
10. [10] Cheng, R., Tay, D.K.C. and Vacca-Galloway, L.L., The motoneuron pools of the triceps and flexor muscles of the Wobbler mouse, a model for motoneuron disease, according to the retrograde transport of horseradish peroxidase, Neurosci. Lett., 40 (Suppl.) (1990) S53.
11. [11] Clark, K.A. and Stirk, G.C., Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue, Br. J. Pharmacol., 80 (1983) 561-565.
12. [12] Coffield, J.A., Miletic, V., Zimmerman, E., Hoffert, M.J. and Brooks, B.R., Demonstration of thyrotropin-releasing hormone immunoreactivity in neurons of the mouse spinal dorsal horn, J. Neurosci., 6 (1986) 1194-1197.
13. [13] Cooper, B.R. and Boyer, C.E., Stimulant action of thyrotropin releasing hormone on cat spinal cord, Neuropharmacology, 17 (1978) 153-156.
14. [14] Court, J.H., McDermott, J.R., Gibson, A.M., Marshall, E., Bloxhan, C.A., Perry, R.H. and Edivordson, J.A., Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase and proline endopeptidase are present in the spinal cord of Wobbler mice but not in human motor neuron disease, J. Neurochem., 49 (1987) 1084-1090.
15. [15] Cuatrecasas, P. and Hollenberg, M.D., Membrane receptors and hormone action, Adv. Protein Chem., (1976) 251-451.
16. [16] Cuello, A.C., Priestly, J.V. and Paxinos, G., Substance P and enkephalin containing pathways. In G. Paxinos (Ed.), The Rat Nervous System, Part 1, Academic Press, Australia, 1985, pp. 441-469.
17. [17] Dowdy, S. and Warden, S., Randomized complete block design. In Statistics for Research, John Wiley and Sons, New York, 1983, pp. 313-322.
18. [18] Dowdy, S. and Wearden, S., Multiple comparison procedure. In Statistics for Research, John Wiley and Sons, New York, 1983, pp. 262-274.
19. [19] Duchen, L.W., Falconer, D.S. and Strich, S.J., Hereditary progressive neurogenic muscular atrophy in the mouse, J. Physiol. (Lond.), 183 (1966) 53-55.
20. [20] Duchen, L.W., Strich, S.J. and Falconer, D.S., An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'Wobbler', J. Neurol. Neurosurg. Psychiatry, 31 (1968) 535-542.
21. [21] Engel, W.K., Siddique, T. and Nicoloff, J.T., Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone, Lancet, ii (1983) 73-75.
22. [22] Faden, A.I., Jacobs, J.P. and Holaday, J.W., Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats, New Engl. J. Med., 305 (1981) 1063-1067.
23. [23] Faden, A.I., Jacobs, T.P. and Smith, M.T., Thyrotropin releasing hormone in experimental spinal injury: dose response and late treatment, Neurology, 31 (1984) 1280-1284.
24. [24] Faden, A.I., Hill, T.G. and Kubek, M.J., Changes in TRH immunoreactivity in spinal cord after experimental spinal injury, Neuropeptides, 7 (1985) 11-18.
25. [25] Faden, A.I., Pilotte, N.S. and Burt, D.R., Experimental spinal cord injury: effects of trauma or ischemia on TRH and muscarinic receptors, Neurology, 36 (1986) 723-726.
26. [26] Falconer, D.S., Wobbler, Mouse News Lett., 15 (1956) 23.
27. [27] Gillberg, P.G., Aquilonius, S.M., Elkemas, S.A., Lundqvist, G. and Winblad, B., Choline acetyltransferase and substance P-like immunoreactivity in the human spinal cord: changes in amyotrophic lateral sclerosis, Brain Res., 250 (1982) 394-397.
28. [28] Geary II, W.A. and Wooten, G.F., Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain, J. Pharmacol. Exp. Ther., 225 (1983) 234-240.
29. [29] Geary II, W.A., Toga, A.W. and Wooten, G.F., Quantitative film autoradiography for tritium: methodological considerations, Brain Res., 337 (1985) 99-108.
30. [30] Gibson, S.J., Polak, J.M., Katagiri, T., Su, H., et al., A comparison of the distributions of eight peptides in spinal cord from normal controls and cases of motor neuron disease with special reference to Onuf's nucleus, Brain Res., (1988) 255-278.
31. [31] Gilbert, R.F.T., Emson, P.C., Hunt, S.P., Bennett, G.W., Marsden, C.A., Sandberg, B.E.B., Steinbusch, H. and Verkofstad, A.A.G., The effects of monoamine neurotoxins on peptides in the rat spinal cord, Neuroscience, 7 (1982) 69-88.
32. [32] Gilbert, R.F.T., Bennett, G.W., Marsden, C.A. and Emson, P.C., The effect of 5-hydroxytryptamine-depleting drugs on peptides in the ventral spinal cord, Eur. J. Pharmacol., 76 (1981) 203-210.
33. [33] Hanson, P.A., Research strategies in infantile spinal muscular atrophy. In J. Gamstoid and H.B. Sarnat (Eds.), Progressive Spinal Muscular Atrophies, Raven Press, New York, 1984, pp. 209-224.
34. [34] Harkness, D.H. and Brownfield, M.S., A thyrotropin-releasing hormone-containing system in the rat dorsal horn separate from serotonin, Brain Res., 384 (1986) 323-333.
35. [35] Hoerliein, B.F., Redding, R.W., Hoff, E.J. and McGuire, J.A., Evaluation of naloxone, crocetin, thyrotropin-releasing hormone, methylprednisolone, partial neglectomy and hemilaminectomy in the treatment of acute spinal cord trauma, J. Am. Anim. Hosp. Assoc., 2 (1985) 67-77.
36. [36] Hokfelt, T., Kellerth, J.O., Nilssoon, G. and Pernow, B., Experimental immunohistochemical studies on the localisation and distribution of substance P in cat primary sensory neurons, Brain Res., 100 (1975) 235-252.
37. [37] Hokfelt, T., Ljungdahl, A., Terenius, L., Eide, R. and Nillsson, G., Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P, Proc. Natl. Acad. Sci. USA, 74 (1977) 3081-3085.
38. [38] Hokfelt, T., Ljungdahl, A., Steinbusch H., Verhofstad, A., Nilsson, G., Broden, E., Pernow, B. and Goldstein, M., Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system, Neuroscience, 3 (1978) 517-538.
39. [39] Hokfelt, T., Lundberg, J.M., Schultzberg, M., Johansson, O. and Ljungdahl, A., Coexistence of peptides and putative transmitters in neurons, Adv. Biochem. Psychopharmacol., 22 (1980) 1-23.
40. [40] Hokfelt, T., Tsuruo, Y., Ulfhake, B., Cullheim, S., Arvidsson, U., Foster, G.A., Schultzberg, M., Schalling, M., Arborelius, L., Freedman, J., Post, C. and Visser, T., Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds, Ann. NY Acad. Sci., 553 (1989) 76-105.
41. [41] Hokfelt, J., Lundberg, M., Shultzberg, M., Johansson, O., Ljungdahl, A. and Rehfeld, J., Coexistence of peptides and putative neurotransmitters in neurons. In J. Costa and M. Trabucchi (Eds.), Neural Peptides and Neuronal Communication, Raven Press, New York, 1980, pp. 1-23.
42. [42] Hokfelt, T., Tsuruo, Y., Ulfhake, B., Cullheim, S., Arvidsson, U., Foster, G.A., Schultzberg, M., Schalling, U., Arborelius, L., Freedman, G., Post, C. and Visser, T., Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. In G. Metcalf and I.M.D. Jackson (Eds.), Thyrotropin-Releasing Hormone: Biomedical Significance, Ann. NY Acad. Sci., 553 (1989) 76-105.
43. [43] Hollenberg, M.D. and Goren, H.J., Ligand-receptor interactions at the cell surface. In G. Poste and S.T. Crooke (Eds.), Mechanisms of Receptor Regulation, Plenum Press, New York, 1985, pp. 323-373.
44. [44] Holtman, J.R., Norman, W.P., Skirboll, L., Dretchen, K.K., Cuello, C., Visser, T.J., Hokfelt, T. and Gillis, R.A., Evidence for 5-hydroxytryptamine, substance P and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus, J. Neurosci., 4 (1984) 1064-1071.
45. [45] Holtz, A., Nystrom, B. and Gerdin, B., Blocking weight-induced spinal cord injury in rats: effects of TRH or naloxone on motor function recovery and spinal cord blood flow, Acta Neurol Scand., 80 (1989) 215-220.
46. 3 receptor binding sites on capsaicin-sensitive fibres in the rat spinal cord, Eur. J. Pharm., (1989) 250-258.
47. [47] Hughes, J.T., Pathology of amyotrophic lateral sclerosis, Adv. Neurol., 36 (1982) 61-74.
48. [48] Ikeda, K., Mitsumoto, H., Wong, V., Cedarbaum, J.M. and Lindsay, R.M., Brain-derived neurotrophic factor slows the progression of Wobbler mouse motor neuron disease, Soc. Neurosci. Abst., 19 (1993) 199.
49. [49] Iwasaki, Y., Kinoshita, M., Ikeda, K. and Shiojima, T., Trophic effects of enkephalin, β-endorphine and dynorphine on ventral spinal cord in culture, Int. J. Neurosci., 50 (1990) 131-135.
50. [50] Jackson, I.M.D., Adelman, L.S., Munsat, T.L., Forte, S. and Lechan, R.M., Amyotrophic lateral sclerosis: thyrotrophin releasing hormone and histidyl proline diskoto piperizine in the spinal cord and cerebrospinal fluid, Neurology, 36 (1986) 1218-1223.
51. [51] Johansson, O., Hokfelt, T., Pernow, B., Jeffcoate, S.L., White, N., Steinberger, H.W.M., Verhofstad, A.A.J., Emson, P.C. and Spindel, E., Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine: substance P, and thyrotropin-releasing hormone-like activity in medullary neurones projecting to the spinal cord, Neuroscience, 6 (1981) 1857-1881.
52. [52] Kozachuk, W., Mitsumoto, H., Salanga, V.D., Beck, G.J. and Wilber, J.F., Thyrotrophin-releasing hormone (TRH) in murine motor neuron disease (the Wobbler mouse), J. Neurol. Sci., 78 (1987) 253-260.
53. [53] Kuhar, M.J. and Ungerstall, J.R., Receptor autoradiography. In J. Henry, K. Yamamura et al. (Eds.), Methods in Neurotransmitter Receptor Analysis, Raven Press, New York, 1990, pp. 177-218.
54. [54] Lange, D.J., Good, P.F. and Bradley, W.G., A therapeutic trial of gangliosides and thymosine in the Wobbler mouse model of motor neuron disease (the Wobbler mouse), J. Neurol. Sci., 78 (1983) 253-260.
55. [55] Ma, W.Y. and Vacca-Galloway, L.L., Reduced branching and length of dendrites detected on cervical spinal cord motoneurons of Wobbler mouse, a model for inherited motoneuron disease, J. Comp. Neurol., 311 (1991) 210-222.
56. [56] Ma, W.Y. and Vacca-Galloway, L.L., Spiny interneurons identified in the normal mouse spinal cord show alterations in the Wobbler mouse: a model for inherited motoneuron disease, Restor. Neurol. Neurosci., 4 (1992) 381-392.
57. [57] Ma, W.Y. and Vacca-Galloway, L.L., A quantitative Golgi-study of the morphological alterations in cervical spinal ventral horn neurons during the motoneuron disease manifested in the Wobbler mouse, Neurosci. Lett., 41 (Suppl.) (1991) S20.
58. [58] Manaker, S., Rainbow, T.C. and Winokur, A., Thyrotropin-releasing hormone (TRH) receptor: localization in rat and human central nervous system. In Quantitative Receptor Autoradiography, Alan R. Liss, New York, 1986, pp. 103-135.
59. [59] Manaker, S., Winokur, A., Rostene, W.H. and Rainbow, T.C., Autoradiography localization of thyrotropin-releasing hormone receptors in the rat central nervous system, J. Neurosci., 5 (1985) 167-174.
60. [60] Mantyh, P.W. and Hunt, S.P., The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the rat and cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin, Brain Res., 332 (1985) 315-324.
61. 3H]SP as the radioligand, Brain Res., 307 (1984) 147-165.
62. [62] Menkes, D.B., Gallager, D.B., Reinhard, J.F. and Aghaganian, G.K., Alpha-1-adrenoceptor denervation supersensitivity in brain: physiological and receptor binding studies. Brain Res., 212 (1983) 1-12.
63. [63] Mitchell, R. and Fleetwood-Walker, S., Substance P, but not TRH modulates the 5-HT autoreceptor in ventral lumbar spinal cord, Eur. J. Pharmacol., 76 (1981) 119-120.
64. [64] Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J.M., Wong, V. and Lindsay, R.M., Arrest of motor neuron disease in Wobbler mice cotreated with CNTF and BDNF, Science, 265 (1994) 1107-1110.
65. [65] Mitsumoto, H., Salgado, E.D. and Negroski, D., Amyotropic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin releasing hormone in clinical trials, Neurology, 36 (1986) 152-159.
66. [66] Munsat, T.L., Mora, J.S., Robinton, J.E., Jackson, I., Lechan, R., Hedlund, W., Taft, J., Reighlin, S. and Scheife, R., Intrathecal TRH in amyotrophic lateral sclerosis: preliminary observations, Neurology, 34 (Suppl. 1) (1984) 239.
67. [67] Myslinski, N.R. and Anderson, E.G., The effects of serotonin precursors on α-and γ-motoneuron activity, J. Pharmacol. Exp. Ther., 204 (1978) 19-26.
68. [68] Nagata, Y., Okuya, M., Watanabe, R. and Honda, M., Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease, Brain Res., 244 (1982) 223-229.
69. [69] Narumi, S. and Fujita, T., Stimulatory effects of substance P and nerve growth factor (NGF) on neurite outgrowth in embryonic chick dorsal root ganglia, Neuropharmacology, 17 (1978) 73-76.
70. [70] Narumi, S. and Maki, Y., Stimulatory effects of substance P on neurite extension and cyclic AMP levels in cultured neuroblastoma cells, J. Neurochem., 30 (1978) 1321-1326.
71. [71] Nicoll, R.A., Excitatory action of TRH on spinal motoneurons, Nature, 265 (1977) 242-243.
72. [72] Nicoll, R.A., The action of thyrotropin-releasing hormone, substance P and related peptides on frog spinal motoneurons, J. Pharmacol. Exp. Ther., 207 (1978) 817.
73. [73] Ono, H. and Fukuda, H., Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord, Neuropharmacology, 21 (1982) 739-744.
74. [74] Otsuka, M. and Konishi, S., Electrophysiology and neurochemical evidence for substance P as a transmitter of primary sensory neurons. In U.S. von Euler and B. Pernow (Eds.), Substance P. Nobel Symposium 37, Raven Press, New York, 1977, pp. 207-214.
75. [75] Otsuka, M. and Konishi, S., Substance P - the first peptide neurotransmitter? In D. Bousfield (Ed.), Neurotransmitters in Action, Elsevier Biomedical Press, Oxford, 1985, pp. 163-169.
76. [76] Otsuka, M., Kanazawa, I., Sugeta, H. and Toyokura, Y., Substance P in the spinal cord and serum of amyotrophic lateral sclerosis. In T. Tsubaki and Y. Tokokura (Eds.), Amyotrophic Lateral Sclerosis, Univ. Park Press, Baltmore, MD, 1978, pp. 405-411.
77. 3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography, J. Neurosci., 3 (1983) 1189-1198.
78. [78] Papapetropoulos, T.A. and Bradley, W.G., Spinal motor neurons in murine muscular dystrophy and spinal muscular atrophy: a quantitative histological study, J. Neurol. Neurosurg. Psychiatry, 35 (1972) 60-65.
79. [79] Patten, B.M. and Croft, S., Spinal cord substance P in amyotrophic lateral sclerosis. In F. Clifford Rose (Ed.), Research Progress in Motor Neurone Disease: Progress in Neurology Series, Pittman, 1984, pp. 283-289.
80. [80] Phillis, J.W. and Kirkpatrick, J.R., Actions of various gastrointestinal peptides on the isolated amphibian spinal cord, Can. J. Physiol. Pharmacol., 57 (1979) 887-899.
81. [81] Pickel, V.M., Reis, D.J. and Leeman, S.E., Ultrastructural localization of substance P in neurons of rat spinal cord, Brain Res., 122 (1977) 534-539.
82. [82] Pirola, C.J., Balda, M.S., Finkielman, S. and Nahmod, V.E., Increase in muscarinic receptors in rat intestines by thyrotropin releasing hormone (TRH), Life Sci., 34 (1984) 1643-1649.
83. [83] Pirola, C.J., Balda, M.S., Finkielman, S. and Nahmod, V.E., Thyrotropin releasing hormone increases the number of muscarinic receptors in the lateral septal area of the rat brain, Brain Res., 273 (1983) 387-391.
84. [84] Pitts, L.H., Ross, A., Chase, G.A. and Faden, A.I., Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries, J. Neurotrauma, 12 (1995) 235-243.
85. [85] Pollin, M.M., McHanwell, S. and Slater, C.R., Loss of motor neurons, from the median nerve motor nucleus of the mutant mouse 'Wobbler', J. Neurocytol., 19 (1990) 29-38.
86. [86] Rainbow, T.C., Bregon, A. and Berck, D.B., Quantitative receptor autoradiography with tritium-labeled ligands: comparison of biochemical and densitometric measurements, J. Neurosci. Methods, 11 (1984) 231-241.
87. [87] Rainbow, T.C., Bleish, W.V., Bregon, A. and McEwen, B.S., Quantitative densitometry of neurotransmitter receptors, J. Neurosci. Methods, 6 (1982) 127-138.
88. [88] Rexed, B., The cytoarchitectonic organization of the spinal cord in the cat, J. Comp. Neurol., 96 (1952) 415-495.
89. [89] Schmidt-Achert, K., Askanas, V. and Engel, W.K., Thyrotropin-releasing hormone enhances choline acetyltransferase and creatine kinase in cultured spinal ventral horn neurons, J. Neurochem., 43 (1984) 586-589.
90. [90] Schoenen, J., Rezuik, M., Delivaide, P.G. and Vanderhaeghin, J.J., Etude immunocytochimique de la distribution spinale de substance P, des enképhalines, de cholecystokinine, et de sérotonin dans la sclérose laterale amyotrophique, C.R. Soc. Biol. Soc. Belgebiol., 179 (1985) 528-534.
91. [91] Seratrice, G., Desnuelle, C., Guelton, C., Meyer-Dutour, A., Richard, P., Braguer, D. and Crevat, A., Clinical evaluation of thyrotropin releasing horomone in amyotrophic lateral sclerosis, Presse Méd., 44 (1985) 487-488.
92. [92] Sharif, N.A., Quantitative autoradiography of TRH receptors in discrete brain regions of different mammalian species. In G. Metcalf and I.M.D. Jackson (Eds.), Thyrotropin-releasing Hormone: Biomedical Significance, Ann. NY Acad. Sci., 553 (1989) 147-175.
93. [93] Shi, J. and Vacca-Galloway, L.L., Thyrotropin releasing hormone (TRH) neurons sprout in cervical spinal cord of Wobbler mouse, Brain Res., 626 (1993) 83-89.
94. [94] Slater, P. and Cross, A.J., Receptors for opioid peptides in brain, Methods Neurosci., 5 (1991) 459-478.
95. [95] Sobue, I., Takayanagi, T., Nakaishi, T., Tsubaki, T., Uono, M. and Kinoshita, M., Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degeneration, J. Neurol. Sci., 61 (1983) 235-248.
96. [96] Tang, F., Cheung, A. and Vacca-Galloway, L.L., Measurement of neuropeptides in the brain and spinal cord of Wobbler mouse: a model for motoneuron disease, Brain Res., 518 (1990) 329-333.
97. 7 spinal cord, Neurosci. Lett., 73 (1987) 3-8.
98. 7-S1 in the adult cat, Neuroscience, 23 (1987) 917-929.
99. [99] Vacca, L.L., Abrahams, S.J. and Naftchi, N.E., A modified peroxidase-antiperoxidase procedure for improved localization of tissue antigens, J. Histochem. Cytochem., 28 (1980) 297-307.
100. [100] Vacca, L.L., Hobbs, J., Abrahams, S.G. and Naftchi, N.E., Ultrastructural localization of substance P immunoreactivity in the ventral horn of the rat spinal cord, Histochemistry, 76 (1982) 33-64.
101. [101] Vacca-Galloway, L.L. and Steinberger, C.C., Substance P neurons sprout in the cervical spinal cord of the Wobbler mouse: a model for motoneuron disease, J. Neurosci. Res., 16 (1986) 657-670.
102. [102] Vacca-Galloway, L.L., Steinberger, C.C., Poole, E. and Menon, C.D., Substance P, thyrotropin releasing hormone, and serotonin neurons sprout in cervical spinal cord of Wobbler mouse: a model for motoneuron disease. In J.L. Henry, R. Couture, A.C. Cuello, G.R. Pelletier and R. Quirion (Eds.), Substance P and Neurokinins, Springer, New York, 1987, pp. 359-362.
103. [103] Vacca-Galloway, L.L. and Zhang, Y.Q., Decreased immunoreactive (IR) calcitonin gene-related peptide correlates with sprouting of IR-peptidergic and serotonergic neuronal processes in spinal cord and during motoneuron disease, Neurosci. Lett., 41 (Suppl.) (1991) S19.
104. [104] Vacca-Galloway, L.L., Zhang Y.Q., Bose, P. and Zhang, S.H., Sprouting of peptidergic and serotonergic neuronal processes during the postnatal development of the Wobbler mouse, a model for motoneuron disease. Fourth IBRO World Congress of Neuroscience, Kyoto, 1995.
105. [105] Walker, J.J. and King, J.S., Ontogenesis of enkephalinergic afferent systems in the opossum cerebellum, Dev. Brain. Res., 48 (1989) 35-58.
106. [106] White, S.R., A comparison of the effects of serotonin, substance P and thyrotropin-releasing hormone on excitability of rat spinal motoneurons in vivo. Brain Res., 335 (1985) 63-70.
107. [107] Whitehouse, P.J., Wamsley, J.K., Zarbin, M.A., Price, D.L., Tourtellotte, W.R. and Kuhar, M.J., Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors, Ann. Neuraol., 14 (1983) 8-16.
108. [108] Winokur, A., Manaker, S. and Kreider, M.S., TRH and TRH receptors in the spinal cord, Ann. NY Acad. Sci., 553 (1989) 314-324.
109. [109] Yarbrough, G.G., On the neuropharmacology of thyrotropin-releasing hormone (TRH), Prog. Neurobiol. 12 (1979) 291-312.
110. 3H) opioid receptors in rat brain, Brain Res., 179 (1979) 255-270.
111. [111] Yung, K.K.L., Tang, F., Fielding, R., Du, Y.H. and Vacca-Galloway, L.L., Alteration in the levels of thyrotropin releasing hormone, substance P and enkephalins in the spinal cord, brainstem, hypothalamus and midbrain of the Wobbler mouse at different stages of the motoneuron disease, Neuroscience, 50 (1992) 209-222.
112. [112] Yung, K.K.L., Tang, F. and Vacca-Galloway, L.L., Alterations in acetylcholinesterase and choline acetyltransferase activities and neuropeptide levels in the ventral spinal cord of the Wobbler mouse during inherited motoneuron disease, Brain Res., 638 (1994) 337-342.
113. [113] Zhang, Y.Q. and Vacca-Galloway, L.L., Decreased immunoreactive (IR) calcitonin gene-related peptide correlates with sprouting of IR-peptidergic and serotonergic neuronal processes in spinal cord and brain nuclei from the Wobbler mouse during motoneuron disease. Brain Res., 578 (1992) 169-177.